XML 24 R11.htm IDEA: XBRL DOCUMENT v3.22.2.2
Trade Receivables
 9 Months Ended
Sep. 30, 2022
Receivables [Abstract]  
Trade Receivables Trade Receivables
Product Sales
Receivables from product sales are recorded for amounts due to the Company related to sales of ORLADEYO and RAPIVAB. At September 30, 2022 and December 31, 2021, receivables related to sales of ORLADEYO were $39,565 and $27,384, respectively. At September 30, 2022 and December 31, 2021, receivables related to sales of RAPIVAB were $28 and $49, respectively. No reserve or allowance amounts were recorded as of both September 30, 2022 and December 31, 2021.
Collaborations
Receivables from collaborations were as follows (in thousands):
September 30, 2022
BilledUnbilledTotal
U.S. Department of Health and Human Services$293 $243 $536 
Shionogi & Co. Ltd.1,893 — 1,893 
Royalty receivables from partners588 — 588 
Total receivables$2,774 $243 $3,017 
December 31, 2021
BilledUnbilledTotal
U.S. Department of Health and Human Services$5 $1,670 $1,675 
Royalty receivables from partners305 — 305 
Total receivables$310 $1,670 $1,980 
As of both September 30, 2022 and December 31, 2021, the Company maintained a reserve of $701 related to royalties associated with Green Cross.